Woods Keith bought TCRX
June 30, 2025 · Form 4 insider transaction
Woods Keith bought 67,000 shares of TScan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
67,000
Price
$0.00
Total value
N/A
InsiderWoods Keith
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 30, 2025
Filing dateJuly 2, 2025
Shares owned after67,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 30, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time.